Literature DB >> 30275776

Utilization of LCP-Tacrolimus (Envarsus XR) in Simultaneous Pancreas and Kidney Transplant Recipients.

Julia Torabi1,2, Alesa Campbell2, Maria Ajaimy1,2, Juan P Rocca1,2, Jay A Graham1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30275776      PMCID： PMC6162119          DOI： 10.31486/toj.18.0011

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


× No keyword cloud information.
  10 in total

1.  OPTN/SRTR 2012 Annual Data Report: pancreas.

Authors:  A K Israni; M A Skeans; S K Gustafson; M A Schnitzler; J L Wainright; R J Carrico; K H Tyler; L A Kades; R Kandaswamy; J J Snyder; B L Kasiske
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

2.  Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation.

Authors:  M Dong; A K Parsaik; W Kremers; A Sun; P Dean; M Prieto; F G Cosio; M J Gandhi; L Zhang; T C Smyrk; M D Stegall; Y C Kudva
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

Review 3.  Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2015-10       Impact factor: 6.447

4.  Letter to the Editor: Mobile Technology Can Improve Adherence and Lessen Tacrolimus Variability in Patients Receiving Kidney Transplants.

Authors:  Julia Torabi; Krystina Choinski; Alesa Courson; Alana Zanetti-Yabur; Juan P Rocca; Jay A Graham
Journal:  Ochsner J       Date:  2017

5.  A Single-Center Experience With Tacrolimus LCP (Envarsus XR) in Pancreas Transplant Recipients.

Authors:  L Kerstenetzky; J L Descourouez; M R Jorgenson; D C Felix; D A Mandelbrot; R R Redfield; J S Odorico
Journal:  Ann Pharmacother       Date:  2017-12-14       Impact factor: 3.154

6.  High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients.

Authors:  T Vanhove; T Vermeulen; P Annaert; E Lerut; D R J Kuypers
Journal:  Am J Transplant       Date:  2016-04-21       Impact factor: 8.086

7.  Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial.

Authors:  K Budde; S Bunnapradist; J M Grinyo; K Ciechanowski; J E Denny; H T Silva; L Rostaing
Journal:  Am J Transplant       Date:  2014-10-02       Impact factor: 8.086

Review 8.  Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

9.  Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.

Authors:  S V Niederhaus; G E Leverson; D F Lorentzen; D J Robillard; H W Sollinger; J D Pirsch; J R Torrealba; J S Odorico
Journal:  Am J Transplant       Date:  2013-09-19       Impact factor: 8.086

10.  Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.

Authors:  Anthony Langone; Steven M Steinberg; Roberto Gedaly; Laurence K Chan; Tariq Shah; Kapil D Sethi; Vincenza Nigro; John C Morgan
Journal:  Clin Transplant       Date:  2015-08-06       Impact factor: 2.863
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.